AB97614

Anti-Factor VII antibody

(1 리뷰)

(10 제품이 사용된 논문 )

Rabbit Polyclonal Factor VII antibody. Suitable for WB and reacts with Mouse, Human samples. Cited in 10 publications. Immunogen corresponding to Recombinant Fragment Protein within Human F7 aa 200 to C-terminus.

2 이미지

Supplier Data

Western blot - Anti-Factor VII antibody (AB97614)

Samples were separated by 12% SDS-PAGE.

All lanes:

Western blot - Anti-Factor VII antibody (ab97614) at 1/500 dilution

All lanes:

Human plasma extracts at 30 µg

Secondary

All lanes:

HRP-conjugated anti-rabbit IgG antibody

Predicted band size: 52 kDa

false

Unknown

Western blot - Anti-Factor VII antibody (AB97614)

10% SDS PAGE

All lanes:

Western blot - Anti-Factor VII antibody (ab97614) at 1/1000 dilution

All lanes:

NIH 3T3 whole cell lysate at 30 µg

Predicted band size: 52 kDa

false

주요 정보

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

Reacts with

Mouse, Human

Applications

applications

Immunogen

Recombinant Fragment Protein within Human F7 aa 200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P08709

style

left-column

style

left-column

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" }, "Monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

style

left-column

style

left-column

특성 및 보관 정보

제형

Liquid

Purification 테크닉

Affinity purification Immunogen

보관 버퍼

pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine

배송 시 보관 조건

Blue Ice

적절한 단기 보관 조건

+4°C

적절한 장기 보관 조건

-20°C

분주 정보

Upon delivery aliquot

보관 정보

Avoid freeze / thaw cycle

style

left-column

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Factor VII also known as factor 7 or factor seven is a plasma glycoprotein with a molecular mass of approximately 50 kDa. It plays an important role in the blood coagulation process. Factor VII is mainly produced in the liver and requires vitamin K for its synthesis. In the inactive form it circulates in the plasma but upon activation to factor 7a it initiates the extrinsic pathway of blood coagulation. This activation is a critical step in hemostasis which helps to prevent excessive bleeding.

Biological function summary

Factor 7a indirectly activates further components in the blood coagulation cascade. Upon activation factor 7a becomes a part of the tissue factor (TF) complex which includes tissue factor expressed on subendothelial cells. The complex triggers the activation of factor IX and factor X propagating the coagulation cascade downstream. This series of activations amplifies the signal for clot formation highlighting factor VII's integral role in initiating coagulation.

Pathways

Factor VII is primarily involved in the extrinsic pathway of the coagulation cascade. This pathway is initiated when factor 7a forms a complex with tissue factor a protein that becomes exposed at injury sites. Factor VII is also indirectly linked to the common coagulation pathway through activation of factor X. The interaction between these pathways ensures efficient and rapid clot formation. Additionally factor IX also interacts with factor VII in the intricate network of coagulation processes that sustain hemostasis.

Deficiencies or dysfunctions in factor VII can lead to coagulopathies such as congenital factor VII deficiency which results in excessively prolonged bleeding. Conversely elevated factor VII activity can contribute to thromboembolic disorders like myocardial infarction. In these conditions factor VII often interacts with proteins like factor X and tissue factor highlighting their clinical significance in managing blood coagulation abnormalities.

style

left-column

style

left-column

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

타겟 정보

Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium (PubMed : 271951).

See full target information F7

대체 명칭 보기

Coagulation factor VII, Proconvertin, Serum prothrombin conversion accelerator, SPCA, F7

style

left-column

제품이 사용된 논문 (10)

Recent publications for all applications. Explore the 전체 목록 and refine your search

iScience 25:104547 PubMed35754738

2022

Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Yuka Hayashi,Ippei Shimizu,Yohko Yoshida,Ryutaro Ikegami,Masayoshi Suda,Goro Katsuumi,Shinya Fujiki,Kazuyuki Ozaki,Manabu Abe,Kenji Sakimura,Shujiro Okuda,Toshiya Hayano,Kazuhiro Nakamura,Kenneth Walsh,Naja Zenius Jespersen,Søren Nielsen,Camilla Scheele,Tohru Minamino

The journal of gene medicine 24:e3398 PubMed34786791

2021

A novel compound heterozygous variant linked to hematuria in a family with hereditary factor VII deficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Ya-Nan Hu,Yu-Mian Gan,Yan-Ping Zhang,Dan-Dan Ruan,Yao-Bin Zhu,Xin-Fu Lin,Zhu-Ting Fang,Li-Sheng Liao,Fa-Qiang Tang,Jie-Wei Luo

Vascular pharmacology 130:106679 PubMed32387621

2020

Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.

Applications

Unspecified application

Species

Unspecified reactive species

Ewa Wypasek,Joanna Natorska,Piotr Mazur,Magdalena Kopytek,Bogusław Gawęda,Przemysław Kapusta,Jacek Madeja,Teresa Iwaniec,Bogusław Kapelak,Anetta Undas

Experimental and therapeutic medicine 17:2945-2952 PubMed30936964

2019

miR-204-5p promotes diabetic retinopathy development via downregulation of microtubule-associated protein 1 light chain 3.

Applications

Unspecified application

Species

Unspecified reactive species

Xin-Bang Mao,Yan-Hua Cheng,Yan-Ying Xu

Iranian journal of biotechnology 16:e1813 PubMed30555841

2018

Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.

Applications

Unspecified application

Species

Unspecified reactive species

Amir Mashayekhi,Shirin Shahbazi,Mirdavood Omrani

Molecular medicine reports 17:2738-2742 PubMed29207137

2017

In vitro expression of mutant factor VII proteins and characterization of their clinical significance.

Applications

Unspecified application

Species

Unspecified reactive species

Amir Mashayekhi,Shirin Shahbazi,Mirdavood Omrani,Reza Mahdian

Molecular therapy. Nucleic acids 9:274-283 PubMed29246306

2017

Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kuang-Tzu Huang,I-Ying Kuo,Ming-Chao Tsai,Chun-Hsien Wu,Li-Wen Hsu,Li-Yu Chen,Chao-Pin Kung,Yu-Fan Cheng,Shigeru Goto,Yu-Wei Chou,Chao-Long Chen,Chih-Che Lin,Kuang-Den Chen

Anticancer research 37:465-473 PubMed28179291

2017

Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Shuo Zhang,Decai Tang,Wenhua Zang,Gang Yin,Jianguo Dai,Y U Sun,Zhijian Yang,Robert M Hoffman,Xiuxia Guo

Cytotechnology 69:317-327 PubMed28070807

2017

Successful synthesis of active human coagulation factor VII by co-expression of mammalian gamma-glutamyl carboxylase and modification of vit.K cycle in Drosophila Schneider S2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Kotomi Nagahashi,Kazuo Umemura,Naohiro Kanayama,Takayuki Iwaki

Cell death & disease 5:e1244 PubMed24853422

2014

Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.

Applications

Species

Human

K-D Chen,C-C Wang,M-C Tsai,C-H Wu,H-J Yang,L-Y Chen,T Nakano,S Goto,K-T Huang,T-H Hu,C-L Chen,C-C Lin

제품이 사용된 논문 모두 보기

style

left-column

style

left-column

style

right-column

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.

자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Anti-Factor VII antibody

Western blot - Anti-Factor VII antibody (AB97614)

Western blot - Anti-Factor VII antibody (AB97614)

주요 정보

Host species

Clonality

Isotype

Carrier free

Reacts with

Applications

Immunogen

대체품

Primary Antibodies

Primary Antibodies

보완 제품

Assay Kits

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Reactivity 정보

특성 및 보관 정보

제형

Purification 테크닉

보관 버퍼

배송 시 보관 조건

적절한 단기 보관 조건

적절한 장기 보관 조건

분주 정보

보관 정보

추가 정보

Biological function summary

Pathways

제품 프로토콜

타겟 정보

대체 명칭 보기

제품이 사용된 논문 (10)

Product promise